Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-524,470
Closed -$16.9M – 190
2016
Q3
$16.9M Hold
524,470
– – 0.6% 39
2016
Q2
$17.5M Buy
+524,470
New +$16.7M 0.9% 36

Other funds holding PFE

Sprott's PFE Position: Q3 2026 in Review

Sprott held its Pfizer (PFE) position steady in Q3 2026 at 9,380 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #217.

Sprott first reported a position in PFE in Q4 2013 and has held it in 15 quarters since. The position peaked at $36.1M in Q2 2016. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Sprott held 9,380 shares of Pfizer worth $268K as of Q3 2026.
  • Sprott left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.01% of Sprott's portfolio in Q3 2026, its #217 holding.
  • Sprott first reported a position in Pfizer in Q4 2013 and has held it in 15 quarters since.
  • Sprott's Pfizer position peaked at $36.1M in Q2 2016.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.